BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30068241)

  • 21. MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells.
    Botta C; Cucè M; Pitari MR; Caracciolo D; Gullà A; Morelli E; Riillo C; Biamonte L; Gallo Cantafio ME; Prabhala R; Mignogna C; Di Vito A; Altomare E; Amodio N; Di Martino MT; Correale P; Rossi M; Giordano A; Munshi NC; Tagliaferri P; Tassone P
    Leukemia; 2018 Apr; 32(4):1003-1015. PubMed ID: 29158557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CircRNA circ_0000190 inhibits the progression of multiple myeloma through modulating miR-767-5p/MAPK4 pathway.
    Feng Y; Zhang L; Wu J; Khadka B; Fang Z; Gu J; Tang B; Xiao R; Pan G; Liu J
    J Exp Clin Cancer Res; 2019 Feb; 38(1):54. PubMed ID: 30728056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lnc NEAT1/miR-29b-3p/Sp1 form a positive feedback loop and modulate bortezomib resistance in human multiple myeloma cells.
    Che F; Ye X; Wang Y; Ma S; Wang X
    Eur J Pharmacol; 2021 Jan; 891():173752. PubMed ID: 33253679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. circIFITM1/miR-802/Foxp1 Axis Participates in Proliferation and Invasion of Lovo Cells.
    Wan Y; He J; Han Z; Wang S; Zhao Y; Zeng D; Tang Y; He Y; Zeng L
    Dis Markers; 2022; 2022():7366337. PubMed ID: 35783017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma.
    Xu JX; Yang Y; Zhang X; Luan XP
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1922-1931. PubMed ID: 32141561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulated microRNA-183 mediates the Jak/Stat signaling pathway to attenuate hippocampal neuron injury in epilepsy rats by targeting Foxp1.
    Feng X; Xiong W; Yuan M; Zhan J; Zhu X; Wei Z; Chen X; Cheng X
    Cell Cycle; 2019 Nov; 18(22):3206-3222. PubMed ID: 31571517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p.
    Pan Y; Zhang Y; Liu W; Huang Y; Shen X; Jing R; Pu J; Wang X; Ju S; Cong H; Chen H
    Cell Death Dis; 2019 Feb; 10(2):106. PubMed ID: 30728351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulation of LncRNA ANRIL mediated by miR-411-3p inhibits the malignant proliferation and tumor stem cell like property of multiple myeloma via hypoxia-inducible factor 1α.
    Wang M; Zhao HY; Zhang JL; Wan DM; Li YM; Jiang ZX
    Exp Cell Res; 2020 Nov; 396(1):112280. PubMed ID: 32961145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulated microRNA‑671‑3p promotes tumor progression by suppressing forkhead box P2 expression in non‑small‑cell lung cancer.
    Li ZY; Zhang ZZ; Bi H; Zhang QD; Zhang SJ; Zhou L; Zhu XQ; Zhou J
    Mol Med Rep; 2019 Oct; 20(4):3149-3159. PubMed ID: 31432170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. microRNA-665 is down-regulated in gastric cancer and inhibits proliferation, invasion, and EMT by targeting PPP2R2A.
    Zhang M; Wang S; Yi A; Qiao Y
    Cell Biochem Funct; 2020 Jun; 38(4):409-418. PubMed ID: 31923339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-3687 Overexpression Promotes Bladder Cancer Cell Growth by Inhibiting the Negative Effect of FOXP1 on Cyclin E2 Transcription.
    Xie Q; Chen C; Li H; Xu J; Wu L; Yu Y; Ren S; Li H; Hua X; Yan H; Rao D; Zhang H; Jin H; Huang H; Huang C
    Mol Ther; 2019 May; 27(5):1028-1038. PubMed ID: 30935821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-449b-5p regulates cell proliferation, migration and radioresistance in cervical cancer by interacting with the transcription suppressor FOXP1.
    Cheng L; Shi X; Huo D; Zhao Y; Zhang H
    Eur J Pharmacol; 2019 Aug; 856():172399. PubMed ID: 31103631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.
    Wang H; Guan X; Tu Y; Zheng S; Long J; Li S; Qi C; Xie X; Zhang H; Zhang Y
    J Exp Clin Cancer Res; 2015 Jun; 34(1):59. PubMed ID: 26063204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1.
    Song Y; Li X; Zeng Z; Li Q; Gong Z; Liao Q; Li X; Chen P; Xiang B; Zhang W; Xiong F; Zhou Y; Zhou M; Ma J; Li Y; Chen X; Li G; Xiong W
    Oncotarget; 2016 Jun; 7(24):36783-36799. PubMed ID: 27167345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genistein inhibits the proliferation of human multiple myeloma cells through suppression of nuclear factor-κB and upregulation of microRNA-29b.
    Xie J; Wang J; Zhu B
    Mol Med Rep; 2016 Feb; 13(2):1627-32. PubMed ID: 26718793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-199a targeting ROCK1 to affect kidney cell proliferation, invasion and apoptosis.
    Qin Z; Wei X; Jin N; Wang Y; Zhao R; Hu Y; Yan W; Li J; Zhou Q
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1920-1925. PubMed ID: 29130345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-181d-5p-FOXP1 feedback loop modulates the progression of osteosarcoma.
    Chen H; Xiao Z; Yu R; Wang Y; Xu R; Zhu X
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1434-1441. PubMed ID: 30031607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and functional role of miR-29b in renal cell carcinoma.
    Xu Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Tong Y
    Int J Clin Exp Pathol; 2015; 8(11):14161-70. PubMed ID: 26823729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mechanism involved in the loss of PTEN expression in NSCLC tumor cells.
    Li G; Zhao J; Peng X; Liang J; Deng X; Chen Y
    Biochem Biophys Res Commun; 2012 Feb; 418(3):547-52. PubMed ID: 22290228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.
    Romero M; Gapihan G; Castro-Vega LJ; Acevedo A; Wang L; Li ZW; El Bouchtaoui M; Di Benedetto M; Ratajczak P; Feugeas JP; Thieblemont C; Saavedra C; Janin A
    Oncotarget; 2017 Mar; 8(10):16243-16258. PubMed ID: 27806315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.